-
Something wrong with this record ?
What will studies of Fulani individuals naturally exposed to malaria teach us about protective immunity to malaria?
M. Troye-Blomberg, C. Arama, J. Quin, I. Bujila, AK. Östlund Farrants,
Language English Country Great Britain
Document type Journal Article, Review
Grant support
PD00217ML
Wellcome Trust - United Kingdom
242059
European Community Seventh Framework Programme (FP7)
LSHP-CT-2004-503578
BioMalPar European Network of Excellence
107740/Z/15/Z9
DELTAS Africa Initiative
UK Government
New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency)
Wellcome Trust - United Kingdom
NLK
Free Medical Journals
from 1997 to 1 year ago
Medline Complete (EBSCOhost)
from 1972-01-01 to 1 year ago
Wiley Free Content
from 1997 to 1 year ago
PubMed
32652609
DOI
10.1111/sji.12932
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Malaria, Falciparum epidemiology immunology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Geographicals
- Africa South of the Sahara MeSH
There are an estimated over 200 million yearly cases of malaria worldwide. Despite concerted international effort to combat the disease, it still causes approximately half a million deaths every year, the majority of which are young children with Plasmodium falciparum infection in sub-Saharan Africa. Successes are largely attributed to malaria prevention strategies, such as insecticide-treated mosquito nets and indoor spraying, as well as improved access to existing treatments. One important hurdle to new approaches for the treatment and prevention of malaria is our limited understanding of the biology of Plasmodium infection and its complex interaction with the immune system of its human host. Therefore, the elimination of malaria in Africa not only relies on existing tools to reduce malaria burden, but also requires fundamental research to develop innovative approaches. Here, we summarize our discoveries from investigations of ethnic groups of West Africa who have different susceptibility to malaria.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20027797
- 003
- CZ-PrNML
- 005
- 20210114152402.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/sji.12932 $2 doi
- 035 __
- $a (PubMed)32652609
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Troye-Blomberg, Marita $u Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
- 245 10
- $a What will studies of Fulani individuals naturally exposed to malaria teach us about protective immunity to malaria? / $c M. Troye-Blomberg, C. Arama, J. Quin, I. Bujila, AK. Östlund Farrants,
- 520 9_
- $a There are an estimated over 200 million yearly cases of malaria worldwide. Despite concerted international effort to combat the disease, it still causes approximately half a million deaths every year, the majority of which are young children with Plasmodium falciparum infection in sub-Saharan Africa. Successes are largely attributed to malaria prevention strategies, such as insecticide-treated mosquito nets and indoor spraying, as well as improved access to existing treatments. One important hurdle to new approaches for the treatment and prevention of malaria is our limited understanding of the biology of Plasmodium infection and its complex interaction with the immune system of its human host. Therefore, the elimination of malaria in Africa not only relies on existing tools to reduce malaria burden, but also requires fundamental research to develop innovative approaches. Here, we summarize our discoveries from investigations of ethnic groups of West Africa who have different susceptibility to malaria.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tropická malárie $x epidemiologie $x imunologie $7 D016778
- 651 _2
- $a subsaharská Afrika $7 D017954
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Arama, Charles $u Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, Malaria Research and Training Centre, University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
- 700 1_
- $a Quin, Jaclyn $u Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden. CEITEC Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Bujila, Ioana $u Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden. Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
- 700 1_
- $a Östlund Farrants, Ann-Kristin $u Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
- 773 0_
- $w MED00010600 $t Scandinavian journal of immunology $x 1365-3083 $g Roč. 92, č. 4 (2020), s. e12932
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32652609 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152400 $b ABA008
- 999 __
- $a ok $b bmc $g 1608132 $s 1118977
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 92 $c 4 $d e12932 $e - $i 1365-3083 $m Scandinavian journal of immunology $n Scand J Immunol $x MED00010600
- GRA __
- $a PD00217ML $p Wellcome Trust $2 United Kingdom
- GRA __
- $a 242059 $p European Community Seventh Framework Programme (FP7)
- GRA __
- $a LSHP-CT-2004-503578 $p BioMalPar European Network of Excellence
- GRA __
- $a 107740/Z/15/Z9 $p DELTAS Africa Initiative
- GRA __
- $p UK Government
- GRA __
- $p New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency)
- GRA __
- $p Wellcome Trust $2 United Kingdom
- LZP __
- $a Pubmed-20210105